SCHEMBL5366237

SCHEMBL5366237

CN(C)c1cnc(-c2ccccc2)n1CCO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.41
KDM4E B2RXH2 4/20 0.41
DHODH Q02127 1/20 0.39
HPGDS O60760 2/20 0.38
TLR7 Q9NYK1 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
TSHR P16473 2/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 3/20 0.37
ALOX15 P16050 1/20 0.36
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
CHEK1 O14757 1/20 0.35
MAPT P10636 1/20 0.35
LIMK1 P53667 1/20 0.35
MAPK14 Q16539 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CKS1B P61024 1/20 0.34
SKP1 P63208 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5378577 0.77 ALDH1A1 (0.50) HSD17B10TSHRALDH1A1KMT2A
SCHEMBL5365634 0.77 HPGDS (0.51) HSD17B10KDM4EHPGDSTLR7TDP1
SCHEMBL5366214 0.76 KDM4E (0.41) HSD17B10KDM4EDHODHHPGDSTLR7
SCHEMBL5374616 0.76 HSD17B10 (0.41) HSD17B10KDM4EDHODHHPGDSTLR7
SCHEMBL5374533 0.72 MAP4K4 (0.41) HSD17B10KDM4ETLR7TDP1ALDH1A1
SCHEMBL5374962 0.71 AVPR1A (0.45) HSD17B10KDM4EHPGDSTDP1TSHR
SCHEMBL5371347 0.71 DHODH (0.43) HSD17B10KDM4EDHODHTLR7TDP1
SCHEMBL5375104 0.71 HSD17B10 (0.40) HSD17B10KDM4EDHODHTLR7TDP1
SCHEMBL5371351 0.71 DHODH (0.43) HSD17B10KDM4EDHODHTDP1TSHR
SCHEMBL18419644 0.70 KDM4E (0.47) HSD17B10KDM4EHPGDSTLR7TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US claimed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US claimed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP claimed
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US disclosed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US disclosed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers KRT18, VIM, NDUFS6 HSD17B10 1960/4885KDM4E 452/4885DHODH 479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.